Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:1-\{[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl\}-1H-1,2,4-triazole
go back to main search page
Accession:CHEBI:83758 term browser browse the term
Definition:An epoxide that is oxirane substituted by a 2-chlorophenyl, 4-fluorophenyl and a 1H-1,2,4-triazol-1-ylmethyl groups.
Synonyms:related_synonym: Formula=C17H13ClFN3O;   InChI=1S/C17H13ClFN3O/c18-15-4-2-1-3-14(15)16-17(23-16,9-22-11-20-10-21-22)12-5-7-13(19)8-6-12/h1-8,10-11,16H,9H2;   InChIKey=ZMYFCFLJBGAQRS-UHFFFAOYSA-N;   SMILES=Fc1ccc(cc1)C1(Cn2cncn2)OC1c1ccccc1Cl


show annotations for term's descendants           Sort by:
 
epoxiconazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aass aminoadipate-semialdehyde synthase decreases expression ISO epoxiconazole results in decreased expression of AASS mRNA CTD PMID:22334560 NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB11 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB11 mRNA CTD PMID:29038839 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression
multiple interactions
EXP epoxiconazole results in increased expression of ABCB1A mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCB1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCB1A mRNA
CTD PMID:25182419 PMID:29038839 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Abcb1b ATP-binding cassette, subfamily B (MDR/TAP), member 1B increases expression EXP epoxiconazole results in increased expression of ABCB1B mRNA CTD PMID:25182419 NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of ABCC2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC2 mRNA
CTD PMID:29038839 NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 increases expression
multiple interactions
ISO
EXP
epoxiconazole results in increased expression of ABCC3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ABCC3 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ABCC3 mRNA
CTD PMID:22334560 PMID:29038839 NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 increases expression ISO epoxiconazole results in increased expression of ABCC4 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
JBrowse link
G Abhd4 abhydrolase domain containing 4, N-acyl phospholipase B increases expression ISO epoxiconazole results in increased expression of ABHD4 mRNA CTD PMID:22334560 NCBI chr15:32,888,233...32,906,861
Ensembl chr15:32,894,938...32,906,850
JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA CTD PMID:29038839 NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388
JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 decreases expression ISO epoxiconazole results in decreased expression of ACAA2 mRNA CTD PMID:22334560 NCBI chr18:70,733,872...70,762,395
Ensembl chr18:70,733,872...70,762,395
JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 increases expression EXP epoxiconazole results in increased expression of ACAD9 mRNA CTD PMID:29038839 NCBI chr 2:122,782,051...122,806,166
Ensembl chr 2:122,782,060...122,805,768
JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 decreases expression ISO epoxiconazole results in decreased expression of ACAT1 mRNA CTD PMID:22334560 NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884
JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ACAT2 mRNA CTD PMID:29038839 NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
JBrowse link
G Acly ATP citrate lyase increases expression EXP epoxiconazole results in increased expression of ACLY mRNA CTD PMID:29038839 NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
JBrowse link
G Aco1 aconitase 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA CTD PMID:29038839 NCBI chr 5:56,425,076...56,481,218
Ensembl chr 5:56,425,024...56,481,218
JBrowse link
G Acot3 acyl-CoA thioesterase 3 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT3 mRNA CTD PMID:29038839 NCBI chr 6:107,531,508...107,537,446
Ensembl chr 6:107,531,528...107,536,789
JBrowse link
G Acot9 acyl-CoA thioesterase 9 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACOT9 mRNA CTD PMID:29038839 NCBI chr  X:43,543,069...43,592,200
Ensembl chr  X:43,543,070...43,592,200
JBrowse link
G Acp2 acid phosphatase 2, lysosomal increases expression ISO epoxiconazole results in increased expression of ACP2 mRNA CTD PMID:22334560 NCBI chr 3:80,020,346...80,030,365
Ensembl chr 3:80,021,440...80,030,363
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression ISO epoxiconazole results in decreased expression of ACSL1 mRNA CTD PMID:22334560 NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
JBrowse link
G Actn1 actinin, alpha 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA CTD PMID:25607892 NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555
JBrowse link
G Adam11 ADAM metallopeptidase domain 11 increases expression ISO epoxiconazole results in increased expression of ADAM11 mRNA CTD PMID:22334560 NCBI chr10:90,731,260...90,749,221
Ensembl chr10:90,731,148...90,749,217
JBrowse link
G Adh1 alcohol dehydrogenase 1 (class I) decreases expression EXP epoxiconazole results in decreased expression of ADH1 mRNA CTD PMID:29038839 NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
JBrowse link
G Adssl1 adenylosuccinate synthase like 1 increases expression ISO epoxiconazole results in increased expression of ADSSL1 mRNA CTD PMID:22334560 NCBI chr 6:137,184,818...137,206,694
Ensembl chr 6:137,184,820...137,206,693
JBrowse link
G Ahctf1 AT hook containing transcription factor 1 decreases expression ISO epoxiconazole results in decreased expression of AHCTF1 mRNA CTD PMID:22334560 NCBI chr13:98,023,528...98,079,138
Ensembl chr13:98,023,430...98,078,946
JBrowse link
G Ahr aryl hydrocarbon receptor increases expression ISO
EXP
epoxiconazole results in increased expression of AHR mRNA CTD PMID:22334560 PMID:25182419 PMID:29038839 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Ahsg alpha-2-HS-glycoprotein decreases expression ISO epoxiconazole results in decreased expression of AHSG mRNA CTD PMID:22334560 NCBI chr11:81,711,269...81,717,594 JBrowse link
G Akap1 A-kinase anchoring protein 1 decreases expression ISO epoxiconazole results in decreased expression of AKAP1 mRNA CTD PMID:22334560 NCBI chr10:76,151,013...76,183,987
Ensembl chr10:76,151,038...76,166,276
JBrowse link
G Akap13 A-kinase anchoring protein 13 decreases expression ISO epoxiconazole results in decreased expression of AKAP13 mRNA CTD PMID:22334560 NCBI chr 1:137,089,558...137,315,272
Ensembl chr 1:137,014,272...137,315,272
JBrowse link
G Akap9 A-kinase anchoring protein 9 decreases expression ISO epoxiconazole results in decreased expression of AKAP9 mRNA CTD PMID:22334560 NCBI chr 4:27,195,346...27,331,582
Ensembl chr 4:27,195,346...27,331,582
JBrowse link
G Akr1b7 aldo-keto reductase family 1, member B7 increases expression ISO epoxiconazole results in increased expression of AKR1B7 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 4:61,850,256...61,879,733
Ensembl chr 4:61,850,348...61,862,526
JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of ALDH1A1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ALDH1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ALDH1A1 mRNA
CTD PMID:25182419 PMID:29038839 NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 decreases expression ISO epoxiconazole results in decreased expression of ALS2 mRNA CTD PMID:22334560 NCBI chr 9:65,961,361...66,034,396
Ensembl chr 9:65,961,346...66,033,871
JBrowse link
G Anxa10 annexin A10 increases expression ISO epoxiconazole results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr16:29,674,699...29,741,521
Ensembl chr16:29,674,793...29,741,465
JBrowse link
G Anxa7 annexin A7 increases expression ISO epoxiconazole results in increased expression of ANXA7 mRNA CTD PMID:22334560 NCBI chr15:4,254,470...4,281,296
Ensembl chr15:4,254,499...4,281,287
JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of APEX1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of APEX1 mRNA CTD PMID:29038839 NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
JBrowse link
G Apoe apolipoprotein E increases expression EXP epoxiconazole results in increased expression of APOE mRNA CTD PMID:28454766 NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
JBrowse link
G Apof apolipoprotein F multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of APOF mRNA CTD PMID:29038839 NCBI chr 7:2,689,501...2,690,938
Ensembl chr 7:2,689,501...2,690,936
JBrowse link
G Ar androgen receptor multiple interactions ISO epoxiconazole inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Arg1 arginase 1 decreases expression ISO epoxiconazole results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863
JBrowse link
G Arl5a ADP-ribosylation factor like GTPase 5A decreases expression ISO epoxiconazole results in decreased expression of ARL5A mRNA CTD PMID:22334560 NCBI chr 3:37,922,544...37,947,434
Ensembl chr 3:37,924,793...37,947,283
JBrowse link
G Arpp19 cAMP-regulated phosphoprotein 19 increases expression ISO epoxiconazole results in increased expression of ARPP19 mRNA CTD PMID:22334560 NCBI chr 8:81,949,577...81,972,054
Ensembl chr 8:81,949,877...81,968,589
JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 increases expression ISO epoxiconazole results in increased expression of ASAH1 mRNA CTD PMID:22334560 NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836
JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ASNS mRNA CTD PMID:29038839 NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
JBrowse link
G Atf5 activating transcription factor 5 decreases expression ISO epoxiconazole results in decreased expression of ATF5 mRNA CTD PMID:22334560 NCBI chr 1:100,807,821...100,812,410
Ensembl chr 1:100,808,241...100,810,522
JBrowse link
G Atf6 activating transcription factor 6 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA CTD PMID:29038839 NCBI chr13:89,053,457...89,242,531
Ensembl chr13:89,055,983...89,242,443
JBrowse link
G Atg16l2 autophagy related 16-like 2 increases expression ISO epoxiconazole results in increased expression of ATG16L2 mRNA CTD PMID:22334560 NCBI chr 1:166,401,271...166,415,078
Ensembl chr 1:166,401,271...166,413,564
JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
increases expression
EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATM mRNA
epoxiconazole results in increased expression of ATM mRNA
CTD PMID:29038839 NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
JBrowse link
G Atp6v0e1 ATPase H+ transporting V0 subunit e1 increases expression ISO epoxiconazole results in increased expression of ATP6V0E mRNA CTD PMID:22334560 NCBI chr10:16,769,857...16,792,930
Ensembl chr10:16,769,666...16,792,909
JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions
increases expression
EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ATP8B1 mRNA
epoxiconazole results in increased expression of ATP8B1 mRNA
CTD PMID:29038839 NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354
JBrowse link
G Atxn7l3b ataxin 7-like 3B decreases expression ISO epoxiconazole results in decreased expression of ATXN7L3B mRNA CTD PMID:22334560 NCBI chr 7:55,600,879...55,604,403
Ensembl chr 7:55,600,889...55,604,403
JBrowse link
G Bace1 beta-secretase 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA CTD PMID:25607892 NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
JBrowse link
G Bace2 beta-secretase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA CTD PMID:25607892 NCBI chr11:37,798,397...37,880,624
Ensembl chr11:37,798,370...37,880,821
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA CTD PMID:25607892 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 decreases expression ISO epoxiconazole results in decreased expression of BHMT2 mRNA CTD PMID:22334560 NCBI chr 2:23,272,320...23,289,266
Ensembl chr 2:23,272,328...23,289,266
JBrowse link
G Bid BH3 interacting domain death agonist decreases expression ISO epoxiconazole results in decreased expression of BID mRNA CTD PMID:22334560 NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
JBrowse link
G Bsn bassoon (presynaptic cytomatrix protein) multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA CTD PMID:25607892 NCBI chr 8:116,873,721...116,965,396
Ensembl chr 8:116,873,721...116,965,396
JBrowse link
G C2cd2 C2 calcium-dependent domain containing 2 decreases expression ISO epoxiconazole results in decreased expression of C2CD2 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr11:38,354,746...38,420,133
Ensembl chr11:38,357,424...38,420,119
JBrowse link
G C4b complement C4B (Chido blood group) decreases expression ISO epoxiconazole results in decreased expression of C4B mRNA CTD PMID:22334560 NCBI chr20:4,302,344...4,316,752
Ensembl chr20:4,302,344...4,316,715
JBrowse link
G Cacna1a calcium voltage-gated channel subunit alpha1 A multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA CTD PMID:25607892 NCBI chr19:25,453,236...25,749,550
Ensembl chr19:25,526,751...25,749,550
JBrowse link
G Cacna1b calcium voltage-gated channel subunit alpha1 B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA CTD PMID:25607892 NCBI chr 3:1,740,026...1,924,959
Ensembl chr 3:1,740,024...1,924,827
JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA CTD PMID:25607892 NCBI chr 4:150,635,808...151,270,790
Ensembl chr 4:150,641,066...150,829,913
JBrowse link
G Cacna1d calcium voltage-gated channel subunit alpha1 D multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA CTD PMID:25607892 NCBI chr16:6,110,294...6,405,022
Ensembl chr16:6,112,150...6,405,117
JBrowse link
G Cacna1g calcium voltage-gated channel subunit alpha1 G multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA CTD PMID:25607892 NCBI chr10:82,129,071...82,197,828
Ensembl chr10:82,129,506...82,197,848
JBrowse link
G Cacna1i calcium voltage-gated channel subunit alpha1 I multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA CTD PMID:25607892 NCBI chr 7:121,521,787...121,619,300
Ensembl chr 7:121,511,097...121,619,283
JBrowse link
G Cacna2d3 calcium voltage-gated channel auxiliary subunit alpha2delta 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA CTD PMID:25607892 NCBI chr16:4,871,348...5,795,825
Ensembl chr16:4,871,650...5,795,825
JBrowse link
G Cacnb1 calcium voltage-gated channel auxiliary subunit beta 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA CTD PMID:25607892 NCBI chr10:85,954,138...85,974,764
Ensembl chr10:85,954,138...85,974,651
JBrowse link
G Cacnb3 calcium voltage-gated channel auxiliary subunit beta 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA CTD PMID:25607892 NCBI chr 7:140,311,120...140,324,902
Ensembl chr 7:140,315,368...140,324,902
JBrowse link
G Cacng2 calcium voltage-gated channel auxiliary subunit gamma 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA CTD PMID:25607892 NCBI chr 7:119,228,112...119,353,332
Ensembl chr 7:119,228,102...119,352,605
JBrowse link
G Cacng6 calcium voltage-gated channel auxiliary subunit gamma 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA CTD PMID:25607892 NCBI chr 1:64,307,684...64,322,124
Ensembl chr 1:64,305,438...64,321,241
JBrowse link
G Cacng7 calcium voltage-gated channel auxiliary subunit gamma 7 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA CTD PMID:25607892 NCBI chr 1:64,374,547...64,405,380
Ensembl chr 1:64,374,603...64,405,149
JBrowse link
G Cadm1 cell adhesion molecule 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA CTD PMID:25607892 NCBI chr 8:51,858,906...52,200,591
Ensembl chr 8:52,127,399...52,189,722
JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA CTD PMID:25607892 NCBI chr14:86,208,876...86,297,727
Ensembl chr14:86,208,901...86,297,652
JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA CTD PMID:25607892 NCBI chr15:3,936,721...3,995,740
Ensembl chr15:3,936,786...3,995,915
JBrowse link
G Capns1 calpain, small subunit 1 increases expression ISO epoxiconazole results in increased expression of CAPNS1 mRNA CTD PMID:22334560 NCBI chr 1:91,058,528...91,064,880 JBrowse link
G Cars cysteinyl-tRNA synthetase decreases expression ISO epoxiconazole results in decreased expression of CARS mRNA CTD PMID:22334560 NCBI chr 1:216,759,367...216,801,652
Ensembl chr 1:216,759,366...216,801,656
JBrowse link
G Casp7 caspase 7 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CASP7 mRNA CTD PMID:29038839 NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
JBrowse link
G Cd36 CD36 molecule increases expression
multiple interactions
ISO
EXP
epoxiconazole results in increased expression of CD36 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CD36 mRNA
CTD PMID:22334560 PMID:29038839 NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
JBrowse link
G Cd44 CD44 molecule (Indian blood group) multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA CTD PMID:25607892 NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
JBrowse link
G Cd81 Cd81 molecule multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA CTD PMID:25607892 NCBI chr 1:216,237,663...216,253,460
Ensembl chr 1:216,237,697...216,253,311
JBrowse link
G Cdc34 cell division cycle 34, ubiqiutin conjugating enzyme increases expression ISO epoxiconazole results in increased expression of CDC34 mRNA CTD PMID:22334560 NCBI chr 7:12,899,957...12,905,339
Ensembl chr 7:12,899,958...12,905,339
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CDKN1A mRNA; [cyproconazole co-treated with epoxiconazole] results in decreased expression of CDKN1A mRNA CTD PMID:29038839 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 increases expression ISO epoxiconazole results in increased expression of CDS2 mRNA CTD PMID:22334560 NCBI chr 3:124,896,657...124,935,221
Ensembl chr 3:124,896,618...124,935,226
JBrowse link
G Cebpz CCAAT/enhancer binding protein zeta decreases expression ISO epoxiconazole results in decreased expression of CEBPZ mRNA CTD PMID:22334560 NCBI chr 6:1,516,804...1,534,488
Ensembl chr 6:1,516,804...1,534,488
JBrowse link
G Ces2c carboxylesterase 2C increases expression
multiple interactions
EXP epoxiconazole results in increased expression of CES2C mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CES2C mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CES2C mRNA
CTD PMID:25182419 PMID:29038839 NCBI chr 1:282,640,752...282,648,319
Ensembl chr 1:282,638,017...282,702,424
JBrowse link
G Ces2h carboxylesterase 2H increases expression ISO epoxiconazole results in increased expression of CES2 mRNA CTD PMID:22334560 NCBI chr19:37,052,555...37,067,176
Ensembl chr19:37,052,556...37,067,156
JBrowse link
G Cggbp1 CGG triplet repeat binding protein 1 decreases expression ISO epoxiconazole results in decreased expression of CGGBP1 mRNA CTD PMID:22334560 NCBI chr11:1,896,166...1,915,603
Ensembl chr11:1,896,209...1,915,587
JBrowse link
G Chd1l chromodomain helicase DNA binding protein 1-like increases expression ISO epoxiconazole results in increased expression of CHD1L mRNA CTD PMID:22334560 NCBI chr 2:199,714,044...199,792,270
Ensembl chr 2:199,716,713...199,771,896
JBrowse link
G Chga chromogranin A multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA CTD PMID:25607892 NCBI chr 6:126,434,226...126,445,569
Ensembl chr 6:126,434,226...126,445,568
JBrowse link
G Chka choline kinase alpha decreases expression ISO epoxiconazole results in decreased expression of CHKA mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:219,076,618...219,126,221
Ensembl chr 1:219,077,771...219,126,220
JBrowse link
G Chst1 carbohydrate sulfotransferase 1 decreases expression EXP epoxiconazole results in decreased expression of CHST1 mRNA CTD PMID:25182419 NCBI chr 3:81,441,785...81,512,829
Ensembl chr 3:81,498,022...81,512,807
JBrowse link
G Cmahp cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene decreases expression ISO epoxiconazole results in decreased expression of CMAH mRNA CTD PMID:22334560 NCBI chr17:42,567,472...42,640,221
Ensembl chr17:42,583,945...42,640,221
JBrowse link
G Comt catechol-O-methyltransferase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of COMT mRNA CTD PMID:29038839 NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CPT2 mRNA CTD PMID:29038839 NCBI chr 5:127,505,646...127,523,016
Ensembl chr 5:127,505,614...127,523,089
JBrowse link
G Creg1 cellular repressor of E1A-stimulated genes 1 increases expression ISO epoxiconazole results in increased expression of CREG1 mRNA CTD PMID:22334560 NCBI chr13:83,972,186...83,984,675
Ensembl chr13:83,972,212...83,984,675
JBrowse link
G Crp C-reactive protein increases expression ISO epoxiconazole results in increased expression of CRP mRNA CTD PMID:22334560 NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
JBrowse link
G Ctsd cathepsin D increases expression ISO epoxiconazole results in increased expression of CTSD mRNA CTD PMID:22334560 NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
JBrowse link
G Ctse cathepsin E multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CTSE mRNA CTD PMID:29038839 NCBI chr13:48,426,833...48,449,493
Ensembl chr13:48,426,820...48,449,490
JBrowse link
G Ctsl cathepsin L increases expression ISO epoxiconazole results in increased expression of CTSL mRNA CTD PMID:22334560 NCBI chr17:1,873,105...1,879,266
Ensembl chr17:1,872,848...1,879,279
JBrowse link
G Ctso cathepsin O increases expression ISO epoxiconazole results in increased expression of CTSO mRNA CTD PMID:22334560 NCBI chr 2:180,857,178...180,881,677 JBrowse link
G Cyb5a cytochrome b5 type A increases expression ISO epoxiconazole results in increased expression of CYB5A mRNA CTD PMID:22334560 NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821
JBrowse link
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in decreased expression of CYP11B1 mRNA CTD PMID:28454766 NCBI chr 7:116,248,759...116,255,205
Ensembl chr 7:116,156,219...116,255,167
JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 increases expression EXP epoxiconazole results in increased expression of CYP11B2 mRNA CTD PMID:28454766 NCBI chr 7:116,155,928...116,161,781
Ensembl chr 7:116,156,219...116,255,167
JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions ISO
EXP
[prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP19A1 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA
CTD PMID:25233012 PMID:25607892 NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions
increases activity
EXP
ISO
epoxiconazole results in increased expression of CYP1A1 mRNA
[epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP1A1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP1A1 mRNA
epoxiconazole results in increased activity of CYP1A1 protein
epoxiconazole results in increased expression of CYP1A1 mRNA; epoxiconazole results in increased expression of CYP1A1 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [epoxiconazole results in increased expression of CYP1A1 mRNA]; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 protein
CTD PMID:25182419 PMID:25233012 PMID:29038839 PMID:29294346 PMID:32194361 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression ISO epoxiconazole results in increased expression of CYP1A2 mRNA CTD PMID:22334560 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases expression
multiple interactions
increases activity
ISO
EXP
epoxiconazole results in increased expression of CYP2B10 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP2B1 protein; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased expression of CYP2B1 mRNA
epoxiconazole results in increased activity of CYP2B1 protein
epoxiconazole results in increased expression of CYP2B1 mRNA
CTD PMID:22334560 PMID:23970803 PMID:25182419 PMID:29038839 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
JBrowse link
G Cyp2b15 cytochrome P450, family 2, subfamily b, polypeptide 15 increases expression EXP epoxiconazole results in increased expression of CYP2B15 mRNA CTD PMID:25182419 NCBI chr 1:251,325,923...251,338,404
Ensembl chr 1:251,325,923...251,338,358
JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of CYP2B2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP2B2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2B2 mRNA
CTD PMID:29038839 NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression
multiple interactions
ISO epoxiconazole results in increased expression of CYP2B9 mRNA
[fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein
CTD PMID:22334560 PMID:23970803 PMID:29294346 NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 increases expression EXP epoxiconazole results in increased expression of CYP2C11 mRNA CTD PMID:29038839 NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
JBrowse link
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 increases expression ISO epoxiconazole results in increased expression of CYP2C55 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:258,074,797...258,139,176
Ensembl chr 1:258,074,860...258,139,176
JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 increases expression
decreases expression
EXP
ISO
epoxiconazole results in increased expression of CYP2C6V1 mRNA
epoxiconazole results in decreased expression of CYP2C19 protein
CTD PMID:25182419 PMID:32194361 NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP2E1 mRNA CTD PMID:29038839 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of CYP3A2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A2 mRNA
CTD PMID:29038839 NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 increases expression
multiple interactions
increases activity
EXP epoxiconazole results in increased expression of CYP3A23-3A1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein; [prochloraz co-treated with cyproconazole co-treated with epoxiconazole] results in increased expression of CYP3A23-3A1 mRNA; [prochloraz co-treated with epoxiconazole co-treated with cyproconazole] results in increased activity of CYP3A23-3A1 protein
epoxiconazole results in increased activity of CYP3A23-3A1 protein
CTD PMID:25182419 PMID:29038839 NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 multiple interactions
increases expression
ISO [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 protein
epoxiconazole results in increased expression of CYP3A4 mRNA; epoxiconazole results in increased expression of CYP3A4 protein
CTD PMID:29294346 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 increases expression EXP epoxiconazole results in increased expression of CYP4B1 mRNA CTD PMID:25182419 NCBI chr 5:134,508,728...134,526,103
Ensembl chr 5:134,508,730...134,526,089
JBrowse link
G Cyp51 cytochrome P450, family 51 decreases activity ISO epoxiconazole results in decreased activity of CYP51A1 protein CTD PMID:16989930 NCBI chr 4:27,175,564...27,194,018
Ensembl chr 4:27,175,243...27,194,018
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions
decreases expression
EXP
ISO
[cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA
epoxiconazole results in decreased expression of CYP7A1 mRNA
CTD PMID:29038839 PMID:32194361 NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431
JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 decreases expression ISO epoxiconazole results in decreased expression of DBT mRNA CTD PMID:22334560 NCBI chr 2:219,563,783...219,592,651
Ensembl chr 2:219,563,783...219,592,650
JBrowse link
G Dcc DCC netrin 1 receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA CTD PMID:25607892 NCBI chr18:66,518,213...67,629,801
Ensembl chr18:66,523,120...67,224,566
JBrowse link
G Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit increases expression ISO epoxiconazole results in increased expression of DDOST mRNA CTD PMID:22334560 NCBI chr 5:156,668,924...156,676,036
Ensembl chr 5:156,668,712...156,676,035
JBrowse link
G Ddx46 DEAD-box helicase 46 decreases expression ISO epoxiconazole results in decreased expression of DDX46 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:9,475,275...9,519,545
Ensembl chr17:9,475,538...9,519,595
JBrowse link
G Ddx6 DEAD-box helicase 6 decreases expression ISO epoxiconazole results in decreased expression of DDX6 mRNA CTD PMID:22334560 NCBI chr 8:48,924,768...48,961,394
Ensembl chr 8:48,925,604...48,958,026
JBrowse link
G Dexi Dexi homolog decreases expression ISO epoxiconazole results in decreased expression of DEXI mRNA CTD PMID:22334560 NCBI chr10:5,199,226...5,211,913
Ensembl chr10:5,199,226...5,211,913
JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA CTD PMID:29038839 NCBI chr12:38,490,230...38,503,344
Ensembl chr12:38,490,230...38,503,330
JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase increases expression EXP epoxiconazole results in increased expression of DLAT mRNA CTD PMID:29038839 NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832
JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA CTD PMID:25607892 NCBI chr11:72,164,566...72,378,895
Ensembl chr11:72,163,749...72,378,895
JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA CTD PMID:25607892 NCBI chr10:56,625,845...56,655,543
Ensembl chr10:56,627,411...56,653,599
JBrowse link
G Dlgap3 DLG associated protein 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA CTD PMID:25607892 NCBI chr 5:145,234,757...145,304,536
Ensembl chr 5:145,257,714...145,304,536
JBrowse link
G Dlgap4 DLG associated protein 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA CTD PMID:25607892 NCBI chr 3:152,752,091...152,846,118
Ensembl chr 3:152,752,091...152,846,118
JBrowse link
G Dmgdh dimethylglycine dehydrogenase decreases expression ISO epoxiconazole results in decreased expression of DMGDH mRNA CTD PMID:22334560 NCBI chr 2:23,289,376...23,370,360
Ensembl chr 2:23,289,374...23,370,477
JBrowse link
G Dnai1 dynein, axonemal, intermediate chain 1 decreases expression ISO epoxiconazole results in decreased expression of DNAI1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 5:57,947,796...58,017,985
Ensembl chr 5:57,947,716...58,017,992
JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression EXP epoxiconazole results in increased expression of DNAJB1 mRNA CTD PMID:29038839 NCBI chr19:24,747,178...24,750,919
Ensembl chr19:24,747,178...24,750,919
JBrowse link
G Doc2a double C2 domain alpha multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA CTD PMID:25607892 NCBI chr 1:198,282,828...198,288,611
Ensembl chr 1:198,284,473...198,288,113
JBrowse link
G Dpagt1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 increases expression ISO epoxiconazole results in increased expression of DPAGT1 mRNA CTD PMID:22334560 NCBI chr 8:48,657,779...48,664,531
Ensembl chr 8:48,657,795...48,664,860
JBrowse link
G Dpp10 dipeptidyl peptidase like 10 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA CTD PMID:25607892 NCBI chr13:39,430,590...41,173,706
Ensembl chr13:39,434,217...39,643,361
JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA CTD PMID:25607892 NCBI chr 4:4,021,021...4,943,675
Ensembl chr 4:4,021,008...4,473,307
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA CTD PMID:25607892 NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627
JBrowse link
G Dusp3 dual specificity phosphatase 3 increases expression ISO epoxiconazole results in increased expression of DUSP3 mRNA CTD PMID:22334560 NCBI chr10:89,904,578...89,918,296
Ensembl chr10:89,904,560...89,918,427
JBrowse link
G Egf epidermal growth factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA CTD PMID:25607892 NCBI chr 2:68,820,616...68,895,537 JBrowse link
G Egfr epidermal growth factor receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA CTD PMID:25607892 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Egr1 early growth response 1 decreases expression EXP epoxiconazole results in decreased expression of EGR1 mRNA CTD PMID:28454766 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
JBrowse link
G Ehd1 EH-domain containing 1 decreases expression EXP epoxiconazole results in decreased expression of EHD1 mRNA CTD PMID:28454766 NCBI chr 1:221,644,867...221,667,242
Ensembl chr 1:221,644,867...221,667,239
JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EHHADH mRNA CTD PMID:29038839 NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of EIF2AK3 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EIF2AK3 mRNA
CTD PMID:29038839 NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694
JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 decreases expression ISO epoxiconazole results in decreased expression of EIF4G2 mRNA CTD PMID:22334560 NCBI chr 1:175,883,362...175,895,510
Ensembl chr 1:175,883,363...175,895,510
JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 increases expression ISO epoxiconazole results in increased expression of ELOVL1 mRNA CTD PMID:22334560 NCBI chr 5:137,255,868...137,260,486
Ensembl chr 5:137,255,908...137,260,483
JBrowse link
G Enho energy homeostasis associated decreases expression ISO epoxiconazole results in decreased expression of ENHO mRNA CTD PMID:22334560 NCBI chr 5:58,018,039...58,019,836
Ensembl chr 5:58,018,039...58,019,836
JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 increases expression ISO epoxiconazole results in increased expression of ENTPD5 mRNA CTD PMID:22334560 NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579
JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of EP300 mRNA CTD PMID:29038839 NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression
multiple interactions
ISO
EXP
epoxiconazole results in increased expression of EPHX1 mRNA
[cyproconazole co-treated with epoxiconazole] results in increased expression of EPHX1 mRNA
CTD PMID:22334560 PMID:25182419 PMID:29038839 NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
JBrowse link
G Ephx2 epoxide hydrolase 2 decreases expression ISO epoxiconazole results in decreased expression of EPHX2 mRNA CTD PMID:22334560 NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA CTD PMID:25607892 NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA CTD PMID:25607892 NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA CTD PMID:25607892 NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644
JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ERCC1 mRNA CTD PMID:29038839 NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
JBrowse link
G Etfa electron transfer flavoprotein subunit alpha decreases expression ISO epoxiconazole results in decreased expression of ETFA mRNA CTD PMID:22334560 NCBI chr 8:60,028,786...60,086,352
Ensembl chr 8:60,028,789...60,086,403
JBrowse link
G Etnppl ethanolamine-phosphate phospho-lyase decreases expression ISO epoxiconazole results in decreased expression of ETNPPL mRNA CTD PMID:22334560 NCBI chr 2:235,738,377...235,760,351
Ensembl chr 2:235,738,416...235,760,352
JBrowse link
G Exosc8 exosome component 8 increases expression ISO epoxiconazole results in increased expression of EXOSC8 mRNA CTD PMID:22334560 NCBI chr 2:143,925,643...143,932,240
Ensembl chr 2:143,925,546...143,931,940
JBrowse link
G F10 coagulation factor X increases expression ISO epoxiconazole results in increased expression of F10 mRNA CTD PMID:22334560 NCBI chr16:81,803,169...81,822,476
Ensembl chr16:81,803,110...81,822,716
JBrowse link
G F5 coagulation factor V decreases expression ISO epoxiconazole results in decreased expression of F5 mRNA CTD PMID:22334560 NCBI chr13:82,479,997...82,535,540
Ensembl chr13:82,479,998...82,535,534
JBrowse link
G Fah fumarylacetoacetate hydrolase decreases expression ISO epoxiconazole results in decreased expression of FAH mRNA CTD PMID:22334560 NCBI chr 1:146,713,663...146,736,339
Ensembl chr 1:146,713,676...146,736,261
JBrowse link
G Fam114a1 family with sequence similarity 114, member A1 increases expression ISO epoxiconazole results in increased expression of FAM114A1 mRNA CTD PMID:22334560 NCBI chr14:44,941,705...45,012,299
Ensembl chr14:44,943,172...45,002,719
JBrowse link
G Fam168a family with sequence similarity 168, member A decreases expression ISO epoxiconazole results in decreased expression of FAM168A mRNA CTD PMID:22334560 NCBI chr 1:165,723,278...165,880,612
Ensembl chr 1:165,724,451...165,878,652
JBrowse link
G Fas Fas cell surface death receptor multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of FAS mRNA CTD PMID:29038839 NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
JBrowse link
G Fasn fatty acid synthase increases expression EXP epoxiconazole results in increased expression of FASN mRNA CTD PMID:29038839 NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
JBrowse link
G Fez2 fasciculation and elongation protein zeta 2 increases expression ISO epoxiconazole results in increased expression of FEZ2 mRNA CTD PMID:22334560 NCBI chr 6:963,903...1,003,955
Ensembl chr 6:963,907...1,004,001
JBrowse link
G Fgf1 fibroblast growth factor 1 decreases expression ISO epoxiconazole results in decreased expression of FGF1 mRNA CTD PMID:22334560 NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
JBrowse link
G Fmr1 FMRP translational regulator 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA CTD PMID:25607892 NCBI chr  X:154,684,924...154,722,369
Ensembl chr  X:154,684,935...154,722,314
JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA CTD PMID:25607892 NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
JBrowse link
G G3bp2 G3BP stress granule assembly factor 2 increases expression ISO epoxiconazole results in increased expression of G3BP2 mRNA CTD PMID:22334560 NCBI chr14:17,437,145...17,523,254
Ensembl chr14:17,492,081...17,520,792
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 decreases expression ISO epoxiconazole results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
JBrowse link
G Gabra4 gamma-aminobutyric acid type A receptor subunit alpha 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA CTD PMID:25607892 NCBI chr14:39,154,072...39,230,994
Ensembl chr14:39,154,529...39,231,695
JBrowse link
G Gabrb1 gamma-aminobutyric acid type A receptor subunit beta1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA CTD PMID:25607892 NCBI chr14:38,631,192...39,112,598
Ensembl chr14:38,643,385...39,112,600
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression ISO epoxiconazole results in increased expression of GADD45B mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
JBrowse link
G Gch1 GTP cyclohydrolase 1 increases expression ISO epoxiconazole results in increased expression of GCH1 mRNA CTD PMID:22334560 NCBI chr15:23,935,011...23,968,971
Ensembl chr15:23,934,585...23,969,011
JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA CTD PMID:25607892 NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
JBrowse link
G Ghr growth hormone receptor decreases expression ISO epoxiconazole results in decreased expression of GHR mRNA CTD PMID:22334560 NCBI chr 2:53,149,225...53,413,954
Ensembl chr 2:53,150,370...53,413,638
JBrowse link
G Glrx glutaredoxin increases expression ISO epoxiconazole results in increased expression of GLRX mRNA CTD PMID:22334560 NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944
JBrowse link
G Glrx5 glutaredoxin 5 increases expression ISO epoxiconazole results in increased expression of GLRX5 mRNA CTD PMID:22334560 NCBI chr 6:128,750,503...128,760,880
Ensembl chr 6:128,750,795...128,760,880
JBrowse link
G Gls glutaminase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA CTD PMID:25607892 NCBI chr 9:54,212,622...54,284,879
Ensembl chr 9:54,212,767...54,284,872
JBrowse link
G Gls2 glutaminase 2 decreases expression ISO epoxiconazole results in decreased expression of GLS2 mRNA CTD PMID:22334560 NCBI chr 7:2,605,679...2,621,853
Ensembl chr 7:2,605,719...2,621,852
JBrowse link
G Glud1 glutamate dehydrogenase 1 decreases expression ISO epoxiconazole results in decreased expression of GLUD1 mRNA CTD PMID:22334560 NCBI chr16:10,661,486...10,695,557
Ensembl chr16:10,662,021...10,695,557
JBrowse link
G Gpc1 glypican 1 decreases expression EXP epoxiconazole results in decreased expression of GPC1 mRNA CTD PMID:28454766 NCBI chr 9:99,998,275...100,026,818
Ensembl chr 9:99,998,275...100,026,818
JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 increases expression EXP epoxiconazole results in increased expression of GPD1 mRNA CTD PMID:29038839 NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA CTD PMID:29038839 NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
JBrowse link
G Gpx4 glutathione peroxidase 4 increases expression ISO epoxiconazole results in increased expression of GPX4 mRNA CTD PMID:22334560 NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA CTD PMID:25607892 NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629
JBrowse link
G Gria4 glutamate ionotropic receptor AMPA type subunit 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA CTD PMID:25607892 NCBI chr 8:1,548,145...2,045,874
Ensembl chr 8:1,548,146...2,045,817
JBrowse link
G Grik1 glutamate ionotropic receptor kainate type subunit 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA CTD PMID:25607892 NCBI chr11:27,811,954...28,213,940
Ensembl chr11:27,811,957...27,971,359
JBrowse link
G Grik2 glutamate ionotropic receptor kainate type subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA CTD PMID:25607892 NCBI chr20:53,791,428...54,517,691
Ensembl chr20:53,789,760...54,517,709
JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA CTD PMID:25607892 NCBI chr 3:2,507,745...2,534,664
Ensembl chr 3:2,506,896...2,534,663
JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA CTD PMID:25607892 NCBI chr 4:169,541,620...170,000,216
Ensembl chr 4:169,560,387...169,999,873
JBrowse link
G Grip1 glutamate receptor interacting protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA CTD PMID:25607892 NCBI chr 7:64,672,723...64,854,939
Ensembl chr 7:64,672,722...64,864,404
JBrowse link
G Grn granulin precursor decreases expression ISO epoxiconazole results in decreased expression of GRN mRNA CTD PMID:22334560 NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
JBrowse link
G Gsr glutathione-disulfide reductase increases expression EXP epoxiconazole results in increased expression of GSR mRNA CTD PMID:25182419 NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
JBrowse link
G Gsta2 glutathione S-transferase alpha 2 increases expression ISO epoxiconazole results in increased expression of GSTA2 mRNA CTD PMID:22334560 NCBI chr 8:85,640,081...85,645,621 JBrowse link
G Gsta5 glutathione S-transferase alpha 5 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of GSTA5 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of GSTA5 mRNA CTD PMID:29038839 NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
JBrowse link
G Gsta6 glutathione S-transferase alpha 6 increases expression ISO epoxiconazole results in increased expression of GSTA2 mRNA CTD PMID:22334560 NCBI chr 9:27,475,273...27,533,939
Ensembl chr 9:27,475,273...27,511,176
JBrowse link
G Gstm1 glutathione S-transferase mu 1 increases expression EXP
ISO
epoxiconazole results in increased expression of GSTM1 mRNA CTD PMID:22334560 PMID:25182419 NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
JBrowse link
G Gstm2 glutathione S-transferase mu 2 increases expression EXP
ISO
epoxiconazole results in increased expression of GSTM2 mRNA CTD PMID:22334560 PMID:25182419 NCBI chr 2:210,778,041...210,782,807
Ensembl chr 2:210,720,704...210,782,856
JBrowse link
G Gstm4 glutathione S-transferase mu 4 increases expression ISO epoxiconazole results in increased expression of GSTM4 mRNA CTD PMID:22334560 NCBI chr 2:210,834,013...210,839,242
Ensembl chr 2:210,833,884...210,839,295
JBrowse link
G Gstm5 glutathione S-transferase, mu 5 increases expression ISO epoxiconazole results in increased expression of GSTM3 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272
JBrowse link
G Gstp1 glutathione S-transferase pi 1 increases expression EXP epoxiconazole results in increased expression of GSTP1 mRNA CTD PMID:25182419 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
JBrowse link
G Gstt1 glutathione S-transferase theta 1 increases expression ISO epoxiconazole results in increased expression of GSTT1 mRNA CTD PMID:22334560 NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
JBrowse link
G Haao 3-hydroxyanthranilate 3,4-dioxygenase decreases expression ISO epoxiconazole results in decreased expression of HAAO mRNA CTD PMID:22334560 NCBI chr 6:7,045,145...7,059,227
Ensembl chr 6:7,045,152...7,058,314
JBrowse link
G Hacd1 3-hydroxyacyl-CoA dehydratase 1 increases expression ISO epoxiconazole results in increased expression of HACD1 mRNA CTD PMID:22334560 NCBI chr17:81,173,238...81,196,012
Ensembl chr17:81,173,713...81,187,739
JBrowse link
G Hadha hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of HADHA mRNA CTD PMID:29038839 NCBI chr 6:27,589,840...27,628,921
Ensembl chr 6:27,589,657...27,629,175
JBrowse link
G Hal histidine ammonia lyase decreases expression ISO epoxiconazole results in decreased expression of HAL mRNA CTD PMID:22334560 NCBI chr 7:34,326,087...34,356,413
Ensembl chr 7:34,326,087...34,356,413
JBrowse link
G Hao1 hydroxyacid oxidase 1 decreases expression ISO epoxiconazole results in decreased expression of HAO1 mRNA CTD PMID:22334560 NCBI chr 3:127,444,900...127,500,709
Ensembl chr 3:127,444,902...127,500,709
JBrowse link
G Hectd1 HECT domain E3 ubiquitin protein ligase 1 decreases expression ISO epoxiconazole results in decreased expression of HECTD1 mRNA CTD PMID:22334560 NCBI chr 6:72,509,658...72,596,285
Ensembl chr 6:72,510,255...72,596,446
JBrowse link
G Hectd2 HECT domain E3 ubiquitin protein ligase 2 decreases expression ISO epoxiconazole results in decreased expression of HECTD2 mRNA CTD PMID:22334560 NCBI chr 1:255,186,729...255,254,307
Ensembl chr 1:255,185,629...255,254,307
JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of HERPUD1 mRNA CTD PMID:29038839 NCBI chr19:11,046,905...11,057,440
Ensembl chr19:11,046,909...11,057,254
JBrowse link
G Hes6 hes family bHLH transcription factor 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HES6 mRNA CTD PMID:25607892 NCBI chr 9:98,549,698...98,551,438
Ensembl chr 9:98,549,705...98,551,438
JBrowse link
G Higd1c HIG1 hypoxia inducible domain family, member 1C increases expression ISO epoxiconazole results in increased expression of HIGD1C mRNA CTD PMID:22334560 NCBI chr 7:142,000,612...142,021,344
Ensembl chr 7:142,001,338...142,020,705
JBrowse link
G Hist2h2be histone cluster 2 H2B family member E decreases expression ISO epoxiconazole results in decreased expression of H2BC21 mRNA CTD PMID:22334560 NCBI chr 2:198,360,837...198,363,399
Ensembl chr 2:198,360,998...198,361,378
JBrowse link
G Hmgn1 high mobility group nucleosome binding domain 1 increases expression ISO epoxiconazole results in increased expression of HMGN1 mRNA CTD PMID:22334560 NCBI chr11:36,474,028...36,479,947
Ensembl chr11:36,474,840...36,479,868
JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 increases expression ISO epoxiconazole results in increased expression of HPRT mRNA CTD PMID:22334560 NCBI chr  X:158,196,640...158,228,815
Ensembl chr  X:158,197,149...158,228,749
JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 increases expression EXP epoxiconazole results in increased expression of HSD17B2 mRNA CTD PMID:25182419 NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891
JBrowse link
G Hspa13 heat shock protein family A (Hsp70) member 13 increases expression ISO epoxiconazole results in increased expression of HSPA13 mRNA CTD PMID:22334560 NCBI chr11:14,146,515...14,160,697
Ensembl chr11:14,144,130...14,160,892
JBrowse link
G Hspb8 heat shock protein family B (small) member 8 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of HSPB8 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of HSPB8 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of HSPB8 mRNA
CTD PMID:29038839 NCBI chr12:45,905,371...45,920,014
Ensembl chr12:45,905,371...45,920,013
JBrowse link
G Ifnar2 interferon alpha and beta receptor subunit 2 increases expression ISO epoxiconazole results in increased expression of IFNAR2 mRNA CTD PMID:22334560 NCBI chr11:31,527,790...31,559,834
Ensembl chr11:31,539,016...31,558,851
JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression ISO epoxiconazole results in decreased expression of IGF1 mRNA CTD PMID:22334560 NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IGF2R mRNA CTD PMID:25607892 NCBI chr 1:48,176,095...48,264,482
Ensembl chr 1:48,176,106...48,264,477
JBrowse link
G Igfals insulin-like growth factor binding protein, acid labile subunit decreases expression ISO epoxiconazole results in decreased expression of IGFALS mRNA CTD PMID:22334560 NCBI chr10:14,240,308...14,243,554
Ensembl chr10:14,240,219...14,243,597
JBrowse link
G Ikbke inhibitor of nuclear factor kappa B kinase subunit epsilon increases expression ISO epoxiconazole results in increased expression of IKBKE mRNA CTD PMID:22334560 PMID:23970803 NCBI chr13:48,031,325...48,056,394
Ensembl chr13:48,031,410...48,056,394
JBrowse link
G Il1rap interleukin 1 receptor accessory protein decreases expression ISO epoxiconazole results in decreased expression of IL1RAP mRNA CTD PMID:22334560 NCBI chr11:77,456,648...77,593,208
Ensembl chr11:77,463,954...77,593,207
JBrowse link
G Il1rapl1 interleukin 1 receptor accessory protein-like 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of IL1RAPL1 mRNA CTD PMID:25607892 NCBI chr  X:55,439,388...57,004,865
Ensembl chr  X:55,439,578...56,765,893
JBrowse link
G Impact impact RWD domain protein increases expression ISO epoxiconazole results in increased expression of IMPACT mRNA CTD PMID:22334560 NCBI chr18:4,325,872...4,346,734
Ensembl chr18:4,325,875...4,346,769
JBrowse link
G Impdh2 inosine monophosphate dehydrogenase 2 decreases expression ISO epoxiconazole results in decreased expression of IMPDH2 mRNA CTD PMID:22334560 NCBI chr 8:117,346,983...117,351,619
Ensembl chr 8:117,347,029...117,351,610
JBrowse link
G Itgax integrin subunit alpha X multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of ITGAX mRNA CTD PMID:29038839 NCBI chr 1:199,555,560...199,576,948
Ensembl chr 1:199,555,722...199,576,932
JBrowse link
G Itih1 inter-alpha trypsin inhibitor, heavy chain 1 decreases expression ISO epoxiconazole results in decreased expression of ITIH1 mRNA CTD PMID:22334560 NCBI chr16:7,012,376...7,026,542
Ensembl chr16:7,012,354...7,026,540
JBrowse link
G Itih2 inter-alpha-trypsin inhibitor heavy chain 2 decreases expression ISO epoxiconazole results in decreased expression of ITIH2 mRNA CTD PMID:22334560 NCBI chr17:72,160,734...72,197,248
Ensembl chr17:72,160,735...72,195,509
JBrowse link
G Itih3 inter-alpha trypsin inhibitor, heavy chain 3 decreases expression ISO epoxiconazole results in decreased expression of ITIH3 mRNA CTD PMID:22334560 NCBI chr16:6,983,779...7,007,288
Ensembl chr16:6,992,062...7,007,287
JBrowse link
G Itm2c integral membrane protein 2C increases expression ISO epoxiconazole results in increased expression of ITM2C mRNA CTD PMID:22334560 NCBI chr 9:92,916,469...92,930,306
Ensembl chr 9:92,916,469...92,930,279
JBrowse link
G Ldha lactate dehydrogenase A decreases expression ISO epoxiconazole results in decreased expression of LDHA mRNA CTD PMID:22334560 NCBI chr 1:102,900,288...102,909,713
Ensembl chr 1:102,900,286...102,909,707
JBrowse link
G Ldlr low density lipoprotein receptor increases expression EXP epoxiconazole results in increased expression of LDLR mRNA CTD PMID:28454766 NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
JBrowse link
G LOC100910717 tankyrase-2-like decreases expression ISO epoxiconazole results in decreased expression of TNKS2 mRNA CTD PMID:22334560 NCBI chr 1:255,478,794...255,532,143
Ensembl chr 1:255,479,261...255,532,143
JBrowse link
G Lonrf3 LON peptidase N-terminal domain and ring finger 3 decreases expression ISO epoxiconazole results in decreased expression of LONRF3 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr  X:122,937,987...122,973,289
Ensembl chr  X:122,938,009...122,973,321
JBrowse link
G Lrat lecithin retinol acyltransferase decreases expression ISO epoxiconazole results in decreased expression of LRAT mRNA CTD PMID:22334560 NCBI chr 2:181,896,304...181,905,366
Ensembl chr 2:181,896,305...181,905,300
JBrowse link
G Lrrc3 leucine rich repeat containing 3 decreases expression ISO epoxiconazole results in decreased expression of LRRC3 mRNA CTD PMID:22334560 NCBI chr20:11,488,514...11,491,354
Ensembl chr20:11,489,456...11,490,406
JBrowse link
G Lrrc7 leucine rich repeat containing 7 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of LRRC7 mRNA CTD PMID:25607892 NCBI chr 2:264,910,594...265,300,860
Ensembl chr 2:264,910,594...265,300,868
JBrowse link
G Lss lanosterol synthase multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of LSS mRNA CTD PMID:29038839 NCBI chr20:12,844,522...12,870,474
Ensembl chr20:12,842,884...12,870,497
JBrowse link
G Luc7l3 LUC7-like 3 pre-mRNA splicing factor decreases expression ISO epoxiconazole results in decreased expression of LUC7L3 mRNA CTD PMID:22334560 NCBI chr10:81,991,147...82,027,119
Ensembl chr10:81,991,147...82,027,119
JBrowse link
G Maea macrophage erythroblast attacher, E3 ubiquitin ligase increases expression ISO epoxiconazole results in increased expression of MAEA mRNA CTD PMID:22334560 NCBI chr14:82,664,248...82,697,673
Ensembl chr14:82,664,249...82,697,673
JBrowse link
G Magi2 membrane associated guanylate kinase, WW and PDZ domain containing 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MAGI2 mRNA CTD PMID:25607892 NCBI chr 4:10,995,241...12,472,423
Ensembl chr 4:10,995,234...11,610,518
JBrowse link
G Magt1 magnesium transporter 1 increases expression ISO epoxiconazole results in increased expression of MAGT1 mRNA CTD PMID:22334560 NCBI chr  X:77,023,423...77,061,603
Ensembl chr  X:77,020,402...77,061,667
JBrowse link
G Manba mannosidase beta multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA CTD PMID:29038839 NCBI chr 2:240,668,213...240,760,264
Ensembl chr 2:240,668,195...240,760,261
JBrowse link
G Mbnl2 muscleblind-like splicing regulator 2 increases expression ISO epoxiconazole results in increased expression of MBNL2 mRNA CTD PMID:22334560 NCBI chr15:105,640,097...105,797,933
Ensembl chr15:105,640,097...105,797,932
JBrowse link
G Mdga2 MAM domain containing glycosylphosphatidylinositol anchor 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MDGA2 mRNA CTD PMID:25607892 NCBI chr 6:88,442,620...89,292,454
Ensembl chr 6:88,447,749...88,917,070
JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions
EXP epoxiconazole results in increased expression of MDM2 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA
CTD PMID:29038839 NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
JBrowse link
G Meig1 meiosis/spermiogenesis associated 1 increases expression ISO epoxiconazole results in increased expression of MEIG1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:78,813,656...78,829,411
Ensembl chr17:78,817,529...78,829,411
JBrowse link
G Mesd mesoderm development LRP chaperone increases expression ISO epoxiconazole results in increased expression of MESD mRNA CTD PMID:22334560 NCBI chr 1:146,030,211...146,043,097
Ensembl chr 1:146,037,426...146,043,097
JBrowse link
G Mettl7a methyltransferase like 7A increases expression ISO epoxiconazole results in increased expression of METTL7A1 mRNA CTD PMID:22334560 NCBI chr 7:141,973,447...142,021,344
Ensembl chr 7:141,973,553...141,981,432
JBrowse link
G Mfsd11 major facilitator superfamily domain containing 11 increases expression ISO epoxiconazole results in increased expression of MFSD11 mRNA CTD PMID:22334560 NCBI chr10:105,796,108...105,815,696
Ensembl chr10:105,796,680...105,815,696
JBrowse link
G Mki67 marker of proliferation Ki-67 increases expression ISO epoxiconazole results in increased expression of MKI67 protein CTD PMID:22334560 NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
JBrowse link
G Mlec malectin increases expression ISO epoxiconazole results in increased expression of MLEC mRNA CTD PMID:22334560 NCBI chr12:47,219,071...47,233,769
Ensembl chr12:47,218,969...47,252,286
JBrowse link
G Mlx MAX dimerization protein MLX multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MLX mRNA CTD PMID:29038839 NCBI chr10:88,997,011...89,002,154
Ensembl chr10:88,997,399...89,002,152
JBrowse link
G Morc3 MORC family CW-type zinc finger 3 increases expression ISO epoxiconazole results in increased expression of MORC3 mRNA CTD PMID:22334560 NCBI chr11:34,051,928...34,094,697
Ensembl chr11:34,051,993...34,094,698
JBrowse link
G Mrpl54 mitochondrial ribosomal protein L54 increases expression ISO epoxiconazole results in increased expression of MRPL54 mRNA CTD PMID:22334560 NCBI chr 7:11,321,057...11,323,577
Ensembl chr 7:11,321,057...11,323,577
JBrowse link
G Mrps18b mitochondrial ribosomal protein S18B multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MRPS18B mRNA CTD PMID:29038839 NCBI chr20:3,344,870...3,350,929
Ensembl chr20:3,344,870...3,350,927
JBrowse link
G Msmo1 methylsterol monooxygenase 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MSMO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MSMO1 mRNA CTD PMID:29038839 NCBI chr16:26,859,441...26,875,880
Ensembl chr16:26,859,397...26,875,973
JBrowse link
G Mt2A metallothionein 2A increases expression ISO epoxiconazole results in increased expression of MT2 mRNA CTD PMID:22334560 NCBI chr19:11,307,966...11,308,740
Ensembl chr19:11,307,967...11,308,740
JBrowse link
G Mthfr methylenetetrahydrofolate reductase increases expression EXP epoxiconazole results in increased expression of MTHFR mRNA CTD PMID:25182419 NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
JBrowse link
G Mug1 murinoglobulin 1 decreases expression ISO epoxiconazole results in decreased expression of MUG1 mRNA CTD PMID:22334560 NCBI chr 4:154,676,382...154,729,288
Ensembl chr 4:154,391,647...154,729,310
JBrowse link
G Myo1b myosin Ib decreases expression ISO epoxiconazole results in decreased expression of MYO1B mRNA CTD PMID:22334560 NCBI chr 9:54,706,005...54,766,054
Ensembl chr 9:54,558,202...54,766,054
JBrowse link
G Nagk N-acetylglucosamine kinase increases expression ISO epoxiconazole results in increased expression of NAGK mRNA CTD PMID:22334560 NCBI chr 4:115,473,848...115,485,027
Ensembl chr 4:115,473,811...115,481,438
JBrowse link
G Naprt nicotinate phosphoribosyltransferase decreases expression ISO epoxiconazole results in decreased expression of NAPRT mRNA CTD PMID:22334560 NCBI chr 7:116,922,979...116,926,436
Ensembl chr 7:116,922,944...116,926,555
JBrowse link
G Nat8 N-acetyltransferase 8 decreases expression ISO epoxiconazole results in decreased expression of NAT8 mRNA CTD PMID:22334560 NCBI chr 4:117,525,963...117,527,443 JBrowse link
G Nat8f1 N-acetyltransferase 8 (GCN5-related) family member 1 decreases expression ISO epoxiconazole results in decreased expression of NAT8F1 mRNA CTD PMID:22334560 NCBI chr 4:117,582,779...117,589,464
Ensembl chr 4:117,582,781...117,589,464
JBrowse link
G Nbr1 NBR1, autophagy cargo receptor decreases expression ISO epoxiconazole results in decreased expression of NBR1 mRNA CTD PMID:22334560 NCBI chr10:89,455,202...89,483,791
Ensembl chr10:89,459,650...89,484,080
JBrowse link
G Ndrg1 N-myc downstream regulated 1 increases expression ISO epoxiconazole results in increased expression of NDRG1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 7:107,734,326...107,775,701
Ensembl chr 7:107,734,323...107,775,714
JBrowse link
G Ndst1 N-deacetylase and N-sulfotransferase 1 decreases expression ISO epoxiconazole results in decreased expression of NDST1 mRNA CTD PMID:22334560 NCBI chr18:55,951,497...56,014,107
Ensembl chr18:55,955,389...55,992,885
JBrowse link
G Nebl nebulette increases expression ISO epoxiconazole results in increased expression of NEBL mRNA CTD PMID:22334560 PMID:23970803 NCBI chr17:84,141,014...84,247,038
Ensembl chr17:84,140,489...84,488,601
JBrowse link
G Nf1 neurofibromin 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NF1 mRNA CTD PMID:25607892 NCBI chr10:66,732,460...66,928,706
Ensembl chr10:66,690,133...66,928,903
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 increases activity ISO epoxiconazole results in increased activity of NFE2L2 protein CTD PMID:30114225 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Nfib nuclear factor I/B decreases expression ISO epoxiconazole results in decreased expression of NFIB mRNA CTD PMID:22334560 NCBI chr 5:100,436,343...100,647,962
Ensembl chr 5:100,439,082...100,647,727
JBrowse link
G Nlgn1 neuroligin 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NLGN1 mRNA CTD PMID:25607892 NCBI chr 2:111,057,291...111,973,681
Ensembl chr 2:111,057,291...111,793,326
JBrowse link
G Notch2 notch receptor 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of NOTCH2 mRNA CTD PMID:25607892 NCBI chr 2:200,187,184...200,320,403
Ensembl chr 2:200,187,179...200,320,215
JBrowse link
G Notch3 notch receptor 3 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NOTCH3 mRNA CTD PMID:25607892 NCBI chr 7:14,138,495...14,189,688
Ensembl chr 7:14,138,495...14,189,688
JBrowse link
G Notch4 notch receptor 4 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NOTCH4 mRNA CTD PMID:25607892 NCBI chr20:4,329,794...4,353,868
Ensembl chr20:4,329,811...4,353,785
JBrowse link
G Nploc4 NPL4 homolog, ubiquitin recognition factor increases expression
multiple interactions
EXP epoxiconazole results in increased expression of NPLOC4 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of NPLOC4 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of NPLOC4 mRNA
CTD PMID:29038839 NCBI chr10:109,553,518...109,610,087
Ensembl chr10:109,552,649...109,610,030
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of NQO1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of NQO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of NQO1 mRNA
CTD PMID:25182419 PMID:29038839 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 decreases expression ISO epoxiconazole results in decreased expression of NR1I3 mRNA CTD PMID:25949234 NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
JBrowse link
G Nrcam neuronal cell adhesion molecule multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRCAM mRNA CTD PMID:25607892 NCBI chr 6:64,297,843...64,867,408
Ensembl chr 6:64,297,888...64,864,996
JBrowse link
G Nrg1 neuregulin 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRG1 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRG1 mRNA CTD PMID:25607892 NCBI chr16:62,969,573...64,065,063
Ensembl chr16:63,837,216...64,057,434
JBrowse link
G Nrxn1 neurexin 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA CTD PMID:25607892 NCBI chr 6:13,886,757...15,191,660
Ensembl chr 6:13,886,740...15,191,660
JBrowse link
G Nrxn2 neurexin 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NRXN2 mRNA CTD PMID:25607892 NCBI chr 1:221,792,191...221,908,047
Ensembl chr 1:221,792,221...221,908,049
JBrowse link
G Nsfl1c NSFL1 cofactor increases expression ISO epoxiconazole results in increased expression of NSFL1C mRNA CTD PMID:22334560 NCBI chr 3:146,980,923...147,005,478
Ensembl chr 3:146,980,923...147,005,439
JBrowse link
G Nsl1 NSL1 component of MIS12 kinetochore complex increases expression ISO epoxiconazole results in increased expression of NSL1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr13:109,669,646...109,697,849
Ensembl chr13:109,669,680...109,696,918
JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of NTRK2 mRNA CTD PMID:25607892 NCBI chr17:5,934,651...6,245,778
Ensembl chr17:5,933,729...6,244,676
JBrowse link
G Oasl 2'-5'-oligoadenylate synthetase-like increases expression ISO epoxiconazole results in increased expression of OASL1 mRNA CTD PMID:22334560 NCBI chr12:47,444,138...47,456,680
Ensembl chr12:47,444,104...47,456,894
JBrowse link
G Obp2a odorant binding protein 2A decreases expression ISO epoxiconazole results in decreased expression of OBP2A mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 3:2,908,684...2,913,362
Ensembl chr 3:2,910,083...2,913,362
JBrowse link
G Ost4 oligosaccharyltransferase complex subunit 4, non-catalytic increases expression ISO epoxiconazole results in increased expression of OST4 mRNA CTD PMID:22334560 NCBI chr 6:26,836,216...26,837,440
Ensembl chr 6:26,836,216...26,837,440
JBrowse link
G P2rx4 purinergic receptor P2X 4 increases expression ISO epoxiconazole results in increased expression of P2RX4 mRNA CTD PMID:22334560 NCBI chr12:39,308,022...39,325,673
Ensembl chr12:39,308,025...39,325,673
JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 increases expression ISO epoxiconazole results in increased expression of PAPSS2 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 1:251,145,264...251,230,716
Ensembl chr 1:251,145,253...251,230,715
JBrowse link
G Pc pyruvate carboxylase decreases expression ISO epoxiconazole results in decreased expression of PCX mRNA CTD PMID:22334560 NCBI chr 1:219,759,157...219,859,854
Ensembl chr 1:219,759,183...219,859,848
JBrowse link
G Pcmtd1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 decreases expression ISO epoxiconazole results in decreased expression of PCMTD1 mRNA CTD PMID:22334560 NCBI chr 5:12,132,657...12,204,376
Ensembl chr 5:12,132,657...12,199,283
JBrowse link
G Pepd peptidase D increases expression ISO epoxiconazole results in increased expression of PEPD mRNA CTD PMID:22334560 NCBI chr 1:90,820,670...91,285,128 JBrowse link
G Pgr progesterone receptor multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PGR mRNA CTD PMID:25607892 NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
JBrowse link
G Pipox pipecolic acid and sarcosine oxidase decreases expression ISO epoxiconazole results in decreased expression of PIPOX mRNA CTD PMID:22334560 NCBI chr10:64,951,986...64,964,865
Ensembl chr10:64,952,119...64,964,862
JBrowse link
G Pla2g12a phospholipase A2, group XIIA increases expression ISO epoxiconazole results in increased expression of PLA2G12A mRNA CTD PMID:22334560 NCBI chr 2:235,311,664...235,327,972
Ensembl chr 2:235,311,719...235,327,972
JBrowse link
G Pla2g6 phospholipase A2 group VI increases expression ISO epoxiconazole results in increased expression of PLA2G6 mRNA CTD PMID:22334560 NCBI chr 7:120,519,479...120,559,716
Ensembl chr 7:120,519,467...120,559,347
JBrowse link
G Plbd1 phospholipase B domain containing 1 increases expression ISO epoxiconazole results in increased expression of PLBD1 mRNA CTD PMID:22334560 NCBI chr 4:170,564,387...170,620,681
Ensembl chr 4:170,564,367...170,620,703
JBrowse link
G Plin2 perilipin 2 decreases expression EXP epoxiconazole results in decreased expression of PLIN2 mRNA CTD PMID:28454766 NCBI chr 5:104,984,413...105,010,863
Ensembl chr 5:104,984,414...105,010,857
JBrowse link
G Plin5 perilipin 5 decreases expression ISO epoxiconazole results in decreased expression of PLIN5 mRNA CTD PMID:22334560 NCBI chr 9:10,956,013...10,961,782
Ensembl chr 9:10,956,056...10,961,782
JBrowse link
G Pnpla7 patatin-like phospholipase domain containing 7 decreases expression ISO epoxiconazole results in decreased expression of PNPLA7 mRNA CTD PMID:22334560 NCBI chr 3:2,182,191...2,261,890
Ensembl chr 3:2,182,957...2,261,878
JBrowse link
G Pon3 paraoxonase 3 increases expression ISO epoxiconazole results in increased expression of PON3 mRNA CTD PMID:22334560 NCBI chr 4:30,311,981...30,338,679
Ensembl chr 4:30,311,982...30,338,679
JBrowse link
G Por cytochrome p450 oxidoreductase increases expression
multiple interactions
ISO
EXP
epoxiconazole results in increased expression of POR mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of POR mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of POR mRNA
CTD PMID:22334560 PMID:29038839 NCBI chr12:23,998,411...24,017,063
Ensembl chr12:23,998,411...24,046,814
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha decreases expression ISO epoxiconazole results in decreased expression of PPARA mRNA CTD PMID:22334560 PMID:25689681 NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions
increases expression
EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of PPARGC1A mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of PPARGC1A mRNA
epoxiconazole results in increased expression of PPARGC1A mRNA
CTD PMID:29038839 NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
JBrowse link
G Ppm1k protein phosphatase, Mg2+/Mn2+ dependent, 1K decreases expression ISO epoxiconazole results in decreased expression of PPM1K mRNA CTD PMID:22334560 NCBI chr 4:88,694,395...88,721,374
Ensembl chr 4:88,694,583...88,718,533
JBrowse link
G Ppp1cc protein phosphatase 1 catalytic subunit gamma increases expression ISO epoxiconazole results in increased expression of PPP1CC mRNA CTD PMID:22334560 NCBI chr12:39,864,302...39,882,030
Ensembl chr12:39,864,295...39,882,030
JBrowse link
G Ppp1r42 protein phosphatase 1, regulatory subunit 42 increases expression ISO epoxiconazole results in increased expression of PPP1R42 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 5:8,911,356...8,956,313
Ensembl chr 5:8,916,633...8,956,119
JBrowse link
G Prg4 proteoglycan 4 increases expression ISO epoxiconazole results in increased expression of PRG4 mRNA CTD PMID:22334560 NCBI chr13:67,672,588...67,688,902
Ensembl chr13:67,672,878...67,688,477
JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of PRKN mRNA CTD PMID:25607892 NCBI chr 1:48,880,015...50,069,998 JBrowse link
G Prlr prolactin receptor decreases expression ISO epoxiconazole results in decreased expression of PRLR mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 2:60,131,410...60,325,686
Ensembl chr 2:60,131,776...60,325,692
JBrowse link
G Prpf19 pre-mRNA processing factor 19 increases expression ISO epoxiconazole results in increased expression of PRPF19 mRNA CTD PMID:22334560 NCBI chr 1:226,947,065...226,958,147
Ensembl chr 1:226,947,105...226,958,144
JBrowse link
G Psap prosaposin increases expression ISO epoxiconazole results in increased expression of PSAP mRNA CTD PMID:22334560 NCBI chr20:29,831,302...29,856,876
Ensembl chr20:29,831,314...29,856,875
JBrowse link
G Psen1 presenilin 1 increases expression ISO epoxiconazole results in increased expression of PSEN1 mRNA CTD PMID:22334560 NCBI chr 6:107,169,514...107,221,000
Ensembl chr 6:107,169,528...107,216,798
JBrowse link
G Psma5 proteasome 20S subunit alpha 5 increases expression ISO epoxiconazole results in increased expression of PSMA5 mRNA CTD PMID:22334560 NCBI chr 2:211,050,344...211,073,706
Ensembl chr 2:211,050,360...211,073,714
JBrowse link
G Psmd12 proteasome 26S subunit, non-ATPase 12 increases expression ISO epoxiconazole results in increased expression of PSMD12 mRNA CTD PMID:22334560 NCBI chr10:95,706,808...95,725,452
Ensembl chr10:95,706,685...95,725,812
JBrowse link
G Rab3gap1 RAB3 GTPase activating protein catalytic subunit 1 decreases expression ISO epoxiconazole results in decreased expression of RAB3GAP1 mRNA CTD PMID:22334560 NCBI chr13:44,578,208...44,649,876
Ensembl chr13:44,615,553...44,648,620
JBrowse link
G Rapgef4 Rap guanine nucleotide exchange factor 4 increases expression ISO epoxiconazole results in increased expression of RAPGEF4 mRNA CTD PMID:22334560 NCBI chr 3:58,632,338...58,925,127
Ensembl chr 3:58,632,476...58,924,038
JBrowse link
G Rbbp8 RB binding protein 8, endonuclease increases expression ISO epoxiconazole results in increased expression of RBBP8 mRNA CTD PMID:22334560 NCBI chr18:3,134,630...3,227,702
Ensembl chr18:3,162,543...3,227,688
JBrowse link
G Rcn2 reticulocalbin 2 increases expression ISO epoxiconazole results in increased expression of RCN2 mRNA CTD PMID:22334560 NCBI chr 8:60,709,851...60,726,938
Ensembl chr 8:60,709,851...60,726,936
JBrowse link
G Reln reelin multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of RELN mRNA CTD PMID:25607892 NCBI chr 4:9,347,533...9,774,257
Ensembl chr 4:9,347,528...9,773,670
JBrowse link
G Rgn regucalcin decreases expression ISO epoxiconazole results in decreased expression of RGN mRNA CTD PMID:22334560 NCBI chr  X:1,833,484...1,848,904
Ensembl chr  X:1,833,492...1,848,904
JBrowse link
G Rhbdd1 rhomboid domain containing 1 increases expression ISO epoxiconazole results in increased expression of RHBDD1 mRNA CTD PMID:22334560 NCBI chr 9:88,110,731...88,229,462
Ensembl chr 9:88,110,731...88,229,479
JBrowse link
G Robo1 roundabout guidance receptor 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ROBO1 mRNA CTD PMID:25607892 NCBI chr11:9,079,291...10,146,302
Ensembl chr11:9,642,365...10,143,317
JBrowse link
G Rras RAS related increases expression ISO epoxiconazole results in increased expression of RRAS mRNA CTD PMID:22334560 NCBI chr 1:101,012,822...101,016,720
Ensembl chr 1:101,012,822...101,016,720
JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 increases expression ISO epoxiconazole results in increased expression of RSAD2 mRNA CTD PMID:22334560 NCBI chr 6:45,655,947...45,669,083
Ensembl chr 6:45,655,954...45,669,148
JBrowse link
G Rxra retinoid X receptor alpha multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of RXRA mRNA CTD PMID:25607892 NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
JBrowse link
G S100a8 S100 calcium binding protein A8 increases expression ISO epoxiconazole results in increased expression of S100A8 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
JBrowse link
G Sar1b secretion associated, Ras related GTPase 1B increases expression ISO epoxiconazole results in increased expression of SAR1B mRNA CTD PMID:22334560 NCBI chr10:37,215,989...37,245,603
Ensembl chr10:37,215,937...37,245,658
JBrowse link
G Scap SREBF chaperone decreases expression ISO epoxiconazole results in decreased expression of SCAP mRNA CTD PMID:22334560 NCBI chr 8:118,551,869...118,628,650
Ensembl chr 8:118,570,503...118,628,651
JBrowse link
G Sec22b SEC22 homolog B, vesicle trafficking protein increases expression ISO epoxiconazole results in increased expression of SEC22B mRNA CTD PMID:22334560 NCBI chr 2:200,076,079...200,096,861
Ensembl chr 2:200,076,054...200,098,076
JBrowse link
G Sec24d SEC24 homolog D, COPII coat complex component increases expression ISO epoxiconazole results in increased expression of SEC24D mRNA CTD PMID:22334560 NCBI chr 2:227,455,704...227,562,801
Ensembl chr 2:227,455,722...227,562,319
JBrowse link
G Sec61a1 SEC61 translocon subunit alpha 1 increases expression ISO epoxiconazole results in increased expression of SEC61A1 mRNA CTD PMID:22334560 NCBI chr 4:120,453,577...120,467,932
Ensembl chr 4:120,453,581...120,467,932
JBrowse link
G Sec61b SEC61 translocon subunit beta increases expression ISO epoxiconazole results in increased expression of SEC61B mRNA CTD PMID:22334560 NCBI chr 5:63,192,322...63,200,532
Ensembl chr 5:63,192,298...63,200,508
JBrowse link
G Selenos selenoprotein S increases expression ISO epoxiconazole results in increased expression of SELENOS mRNA CTD PMID:22334560 NCBI chr 1:126,979,579...126,989,344
Ensembl chr 1:126,979,575...126,989,344
JBrowse link
G Serpina6 serpin family A member 6 increases expression ISO epoxiconazole results in increased expression of SERPINA6 mRNA CTD PMID:22334560 NCBI chr 6:127,523,948...127,534,178
Ensembl chr 6:127,523,906...127,534,247
JBrowse link
G Serpina9 serpin family A member 9 decreases expression ISO epoxiconazole results in decreased expression of SERPINA9 mRNA CTD PMID:22334560 NCBI chr 6:127,662,348...127,680,232
Ensembl chr 6:127,662,813...127,679,951
JBrowse link
G Sf3b2 splicing factor 3b, subunit 2 decreases expression ISO epoxiconazole results in decreased expression of SF3B2 mRNA CTD PMID:22334560 NCBI chr 1:220,645,685...220,665,611
Ensembl chr 1:220,645,672...220,665,603
JBrowse link
G Sgpl1 sphingosine-1-phosphate lyase 1 increases expression ISO epoxiconazole results in increased expression of SGPL1 mRNA CTD PMID:22334560 NCBI chr20:30,699,936...30,769,178
Ensembl chr20:30,699,872...30,749,940
JBrowse link
G Shank2 SH3 and multiple ankyrin repeat domains 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SHANK2 mRNA CTD PMID:25607892 NCBI chr 1:217,149,156...217,593,950
Ensembl chr 1:217,151,166...217,592,763
JBrowse link
G Siae sialic acid acetylesterase increases expression ISO epoxiconazole results in increased expression of SIAE mRNA CTD PMID:22334560 NCBI chr 8:40,078,269...40,113,514
Ensembl chr 8:40,078,269...40,113,514
JBrowse link
G Sirpa signal-regulatory protein alpha increases expression ISO epoxiconazole results in increased expression of SIRPA mRNA CTD PMID:22334560 NCBI chr 3:122,113,735...122,152,478
Ensembl chr 3:122,114,108...122,152,477
JBrowse link
G Slc10a1 solute carrier family 10 member 1 increases expression ISO epoxiconazole results in increased expression of SLC10A1 mRNA CTD PMID:22334560 NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355
JBrowse link
G Slc13a3 solute carrier family 13 member 3 increases expression ISO epoxiconazole results in increased expression of SLC13A3 mRNA CTD PMID:22334560 NCBI chr 3:162,084,336...162,147,398
Ensembl chr 3:162,084,315...162,147,393
JBrowse link
G Slc16a12 solute carrier family 16, member 12 increases expression ISO epoxiconazole results in increased expression of SLC16A12 mRNA CTD PMID:22334560 NCBI chr 1:252,976,071...253,054,500
Ensembl chr 1:252,976,644...253,000,760
JBrowse link
G Slc1a2 solute carrier family 1 member 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A2 mRNA CTD PMID:25607892 NCBI chr 3:92,518,679...92,665,731
Ensembl chr 3:92,640,752...92,665,644
JBrowse link
G Slc1a6 solute carrier family 1 member 6 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLC1A6 mRNA CTD PMID:25607892 NCBI chr 7:13,730,101...13,758,170
Ensembl chr 7:13,730,253...13,751,271
JBrowse link
G Slc23a1 solute carrier family 23 member 1 increases expression ISO epoxiconazole results in increased expression of SLC23A1 mRNA CTD PMID:22334560 NCBI chr18:28,413,910...28,428,133
Ensembl chr18:28,414,009...28,428,117
JBrowse link
G Slc23a2 solute carrier family 23 member 2 increases expression ISO epoxiconazole results in increased expression of SLC23A2 mRNA CTD PMID:22334560 NCBI chr 3:124,632,491...124,842,225
Ensembl chr 3:124,632,492...124,724,252
JBrowse link
G Slc25a15 solute carrier family 25 member 15 decreases expression ISO epoxiconazole results in decreased expression of SLC25A15 mRNA CTD PMID:22334560 NCBI chr16:74,505,318...74,554,523
Ensembl chr16:74,531,564...74,554,529
JBrowse link
G Slc25a22 solute carrier family 25 member 22 decreases expression ISO epoxiconazole results in decreased expression of SLC25A22 mRNA CTD PMID:22334560 NCBI chr 1:214,410,388...214,418,236
Ensembl chr 1:214,410,417...214,414,897
JBrowse link
G Slc25a37 solute carrier family 25 member 37 increases expression ISO epoxiconazole results in increased expression of SLC25A37 mRNA CTD PMID:22334560 NCBI chr15:51,125,764...51,168,384
Ensembl chr15:51,128,268...51,168,384
JBrowse link
G Slc39a11 solute carrier family 39, member 11 increases expression ISO epoxiconazole results in increased expression of SLC39A11 mRNA CTD PMID:22334560 NCBI chr10:101,754,842...102,169,100
Ensembl chr10:101,754,830...102,084,035
JBrowse link
G Slc48a1 solute carrier family 48 member 1 increases expression ISO epoxiconazole results in increased expression of SLC48A1 mRNA CTD PMID:22334560 NCBI chr 7:139,271,698...139,279,499
Ensembl chr 7:139,271,698...139,279,499
JBrowse link
G Slco1a4 solute carrier organic anion transporter family, member 1a4 increases expression ISO epoxiconazole results in increased expression of SLCO1A4 mRNA CTD PMID:22334560 NCBI chr 4:175,969,549...176,026,227
Ensembl chr 4:175,969,549...176,026,163
JBrowse link
G Slit1 slit guidance ligand 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SLIT1 mRNA CTD PMID:25607892 NCBI chr 1:260,843,481...260,992,366
Ensembl chr 1:260,843,483...260,992,366
JBrowse link
G Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 decreases expression ISO epoxiconazole results in decreased expression of SMARCA4 mRNA CTD PMID:22334560 NCBI chr 8:22,648,323...22,739,468
Ensembl chr 8:22,648,323...22,739,468
JBrowse link
G Smpd3 sphingomyelin phosphodiesterase 3 increases expression ISO epoxiconazole results in increased expression of SMPD3 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr19:38,237,963...38,321,572
Ensembl chr19:38,237,965...38,321,528
JBrowse link
G Snx17 sorting nexin 17 decreases expression ISO epoxiconazole results in decreased expression of SNX17 mRNA CTD PMID:22334560 NCBI chr 6:26,541,137...26,546,650
Ensembl chr 6:26,541,138...26,546,545
JBrowse link
G Spcs2 signal peptidase complex subunit 2 increases expression ISO epoxiconazole results in increased expression of SPCS2 mRNA CTD PMID:22334560 NCBI chr 1:164,829,896...164,849,749
Ensembl chr 1:164,829,896...164,849,749
JBrowse link
G Sptbn2 spectrin, beta, non-erythrocytic 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of SPTBN2 mRNA CTD PMID:25607892 NCBI chr 1:219,964,429...220,006,811
Ensembl chr 1:219,964,429...220,005,068
JBrowse link
G Srd5a1 steroid 5 alpha-reductase 1 increases expression ISO epoxiconazole results in increased expression of SRD5A1 mRNA CTD PMID:22334560 NCBI chr 1:36,320,504...36,354,694
Ensembl chr 1:36,320,461...36,354,756
JBrowse link
G Srpra SRP receptor subunit alpha increases expression ISO epoxiconazole results in increased expression of SRPRA mRNA CTD PMID:22334560 NCBI chr 8:36,410,683...36,416,766
Ensembl chr 8:36,410,683...36,416,296
JBrowse link
G Srxn1 sulfiredoxin 1 increases expression ISO epoxiconazole results in increased expression of SRXN1 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr 3:147,608,850...147,614,410
Ensembl chr 3:147,609,095...147,632,801
JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of STAR mRNA CTD PMID:28454766 NCBI chr16:71,036,204...71,040,847
Ensembl chr16:71,036,204...71,040,847
JBrowse link
G Stat5b signal transducer and activator of transcription 5B decreases activity ISO epoxiconazole results in decreased activity of STAT5B protein CTD PMID:30114225 NCBI chr10:88,686,207...88,712,313
Ensembl chr10:88,686,207...88,754,829
JBrowse link
G Stbd1 starch binding domain 1 increases expression ISO
EXP
epoxiconazole results in increased expression of STBD1 mRNA CTD PMID:22334560 PMID:29038839 NCBI chr14:16,976,355...16,979,760
Ensembl chr14:16,976,356...16,979,760
JBrowse link
G Stmn2 stathmin 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA CTD PMID:25607892 NCBI chr 2:95,424,251...95,471,900
Ensembl chr 2:95,424,251...95,472,115
JBrowse link
G Sts steroid sulfatase multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of STS mRNA CTD PMID:25607892 NCBI chr  X:45,420,418...45,428,748
Ensembl chr  X:45,420,596...45,428,750
JBrowse link
G Stt3a STT3 oligosaccharyltransferase complex catalytic subunit A increases expression ISO epoxiconazole results in increased expression of STT3A mRNA CTD PMID:22334560 NCBI chr 8:39,204,218...39,243,751
Ensembl chr 8:39,181,163...39,243,882
JBrowse link
G Stxbp1 syntaxin binding protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STXBP1 mRNA CTD PMID:25607892 NCBI chr 3:11,823,779...11,885,479
Ensembl chr 3:11,823,785...11,885,417
JBrowse link
G Syngap1 synaptic Ras GTPase activating protein 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of SYNGAP1 mRNA CTD PMID:25607892 NCBI chr20:5,535,434...5,564,657
Ensembl chr20:5,535,432...5,564,437
JBrowse link
G Syp synaptophysin multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of SYP mRNA CTD PMID:25607892 NCBI chr  X:15,694,699...15,709,244
Ensembl chr  X:15,695,566...15,707,436
JBrowse link
G Tgfa transforming growth factor alpha increases expression ISO epoxiconazole results in increased expression of TGFA mRNA CTD PMID:22334560 NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TGFB1 mRNA CTD PMID:25607892 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
JBrowse link
G Tgfbr2 transforming growth factor, beta receptor 2 increases expression ISO epoxiconazole results in increased expression of TGFBR2 mRNA CTD PMID:22334560 NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
JBrowse link
G Thoc2 THO complex 2 decreases expression ISO epoxiconazole results in decreased expression of THOC2 mRNA CTD PMID:22334560 NCBI chr  X:128,153,824...128,268,327
Ensembl chr  X:128,161,895...128,268,322
JBrowse link
G Timm10b translocase of inner mitochondrial membrane 10B multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of TIMM10B mRNA CTD PMID:29038839 NCBI chr 1:170,471,265...170,474,111
Ensembl chr 1:170,471,238...170,474,113
JBrowse link
G Tlr2 toll-like receptor 2 increases expression ISO epoxiconazole results in increased expression of TLR2 mRNA CTD PMID:22334560 NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
JBrowse link
G Tm9sf4 transmembrane 9 superfamily member 4 increases expression ISO epoxiconazole results in increased expression of TM9SF4 mRNA CTD PMID:22334560 NCBI chr 3:148,635,822...148,689,961
Ensembl chr 3:148,635,775...148,688,553
JBrowse link
G Tmbim4 transmembrane BAX inhibitor motif containing 4 increases expression ISO epoxiconazole results in increased expression of TMBIM4 mRNA CTD PMID:22334560 NCBI chr 7:64,987,859...65,002,447
Ensembl chr 7:64,987,859...65,002,455
JBrowse link
G Tmed10 transmembrane p24 trafficking protein 10 increases expression ISO epoxiconazole results in increased expression of TMED10 mRNA CTD PMID:22334560 NCBI chr 6:109,169,739...109,205,004
Ensembl chr 6:109,169,741...109,205,004
JBrowse link
G Tmed3 transmembrane p24 trafficking protein 3 increases expression ISO epoxiconazole results in increased expression of TMED3 mRNA CTD PMID:22334560 NCBI chr 8:97,075,194...97,083,107
Ensembl chr 8:97,075,160...97,083,120
JBrowse link
G Tmem109 transmembrane protein 109 increases expression ISO epoxiconazole results in increased expression of TMEM109 mRNA CTD PMID:22334560 NCBI chr 1:226,925,114...226,935,710
Ensembl chr 1:226,925,117...226,935,689
JBrowse link
G Tmem167a transmembrane protein 167A increases expression ISO epoxiconazole results in increased expression of TMEM167 mRNA CTD PMID:22334560 NCBI chr 2:18,927,544...18,946,110
Ensembl chr 2:18,937,458...18,943,561
JBrowse link
G Tmem176a transmembrane protein 176A increases expression ISO epoxiconazole results in increased expression of TMEM176A mRNA CTD PMID:22334560 NCBI chr 4:78,458,735...78,462,415
Ensembl chr 4:78,458,625...78,462,423
JBrowse link
G Tmem176b transmembrane protein 176B increases expression ISO epoxiconazole results in increased expression of TMEM176B mRNA CTD PMID:22334560 NCBI chr 4:78,450,724...78,458,600
Ensembl chr 4:78,450,724...78,458,179
JBrowse link
G Tmem43 transmembrane protein 43 increases expression ISO epoxiconazole results in increased expression of TMEM43 mRNA CTD PMID:22334560 NCBI chr 4:123,118,468...123,133,610
Ensembl chr 4:123,118,468...123,133,609
JBrowse link
G Tmx2 thioredoxin-related transmembrane protein 2 increases expression ISO epoxiconazole results in increased expression of TMX2 mRNA CTD PMID:22334560 NCBI chr 3:72,073,429...72,081,079
Ensembl chr 3:72,073,431...72,081,079
JBrowse link
G Tnfrsf19 TNF receptor superfamily member 19 increases expression ISO epoxiconazole results in increased expression of TNFRSF19 mRNA CTD PMID:22334560 PMID:23970803 NCBI chr15:41,249,820...41,316,203
Ensembl chr15:41,246,308...41,338,284
JBrowse link
G Tnks2 tankyrase 2 decreases expression ISO epoxiconazole results in decreased expression of TNKS2 mRNA CTD PMID:22334560
G Tor1b torsin family 1, member B increases expression ISO epoxiconazole results in increased expression of TOR1B mRNA CTD PMID:22334560 NCBI chr 3:9,792,818...9,798,924
Ensembl chr 3:9,792,899...9,798,923
JBrowse link
G Tsc2 TSC complex subunit 2 multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of TSC2 mRNA CTD PMID:25607892 NCBI chr10:13,962,006...13,996,684
Ensembl chr10:13,961,947...13,996,584
JBrowse link
G Ttc39c tetratricopeptide repeat domain 39C decreases expression ISO epoxiconazole results in decreased expression of TTC39C mRNA CTD PMID:22334560 NCBI chr18:3,958,424...4,080,028
Ensembl chr18:3,958,432...4,080,025
JBrowse link
G Txn1 thioredoxin 1 increases expression ISO epoxiconazole results in increased expression of TXN1 mRNA CTD PMID:22334560 NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
JBrowse link
G Txndc17 thioredoxin domain containing 17 increases expression ISO epoxiconazole results in increased expression of TXNDC17 mRNA CTD PMID:22334560 NCBI chr10:58,776,792...58,779,764
Ensembl chr10:58,776,792...58,779,764
JBrowse link
G Uba5 ubiquitin-like modifier activating enzyme 5 increases expression ISO epoxiconazole results in increased expression of UBA5 mRNA CTD PMID:22334560 NCBI chr 8:112,578,607...112,594,192
Ensembl chr 8:112,578,590...112,594,261
JBrowse link
G Ubb ubiquitin B increases expression ISO epoxiconazole results in increased expression of UBB mRNA CTD PMID:22334560 NCBI chr10:48,880,231...48,881,896
Ensembl chr10:48,881,049...48,881,881
JBrowse link
G Ubn1 ubinuclein 1 decreases expression ISO epoxiconazole results in decreased expression of UBN1 mRNA CTD PMID:22334560 NCBI chr10:10,690,224...10,725,655
Ensembl chr10:10,690,224...10,725,655
JBrowse link
G Ubqln2 ubiquilin 2 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of UBQLN2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of UBQLN2 mRNA CTD PMID:29038839 NCBI chr  X:18,723,313...18,726,732
Ensembl chr  X:18,723,341...18,726,732
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 increases expression
multiple interactions
EXP epoxiconazole results in increased expression of UGT1A1 mRNA
[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of UGT1A1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT1A1 mRNA
CTD PMID:29038839 NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
G Ugt1a9 UDP glucuronosyltransferase family 1 member A9 increases expression ISO epoxiconazole results in increased expression of UGT1A9 mRNA CTD PMID:22334560 NCBI chr 9:95,161,157...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
G Ugt2b17 UDP glucuronosyltransferase family 2 member B17 multiple interactions
increases expression
EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA
epoxiconazole results in increased expression of UGT2B1 mRNA
CTD PMID:29038839 NCBI chr14:22,724,399...22,736,148
Ensembl chr14:22,724,070...22,825,444
JBrowse link
G Ugt2b7 UDP glucuronosyltransferase family 2 member B7 increases expression ISO epoxiconazole results in increased expression of UGT2B34 mRNA CTD PMID:22334560 NCBI chr14:22,597,103...22,619,968 JBrowse link
G Unc5b unc-5 netrin receptor B multiple interactions EXP [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of UNC5B mRNA CTD PMID:25607892 NCBI chr20:30,339,680...30,406,593
Ensembl chr20:30,339,673...30,406,295
JBrowse link
G Vps29 VPS29 retromer complex component increases expression ISO epoxiconazole results in increased expression of VPS29 mRNA CTD PMID:22334560 NCBI chr12:39,690,069...39,699,114
Ensembl chr12:39,690,069...39,699,113
JBrowse link
G Vti1b vesicle transport through interaction with t-SNAREs 1B increases expression ISO epoxiconazole results in increased expression of VTI1B mRNA CTD PMID:22334560 NCBI chr 6:102,340,261...102,353,612
Ensembl chr 6:102,339,857...102,353,403
JBrowse link
G Vtn vitronectin decreases expression ISO epoxiconazole results in decreased expression of VTN mRNA CTD PMID:22334560 NCBI chr10:65,767,960...65,771,040
Ensembl chr10:65,767,053...65,771,038
JBrowse link
G Wdr18 WD repeat domain 18 increases expression ISO epoxiconazole results in increased expression of WDR18 mRNA CTD PMID:22334560 NCBI chr 7:12,561,318...12,569,120
Ensembl chr 7:12,561,324...12,569,143
JBrowse link
G Xiap X-linked inhibitor of apoptosis decreases expression ISO epoxiconazole results in decreased expression of XIAP mRNA CTD PMID:22334560 NCBI chr  X:128,409,425...128,455,786
Ensembl chr  X:128,409,472...128,453,000
JBrowse link
G Xrcc1 X-ray repair cross complementing 1 multiple interactions EXP [cyproconazole co-treated with epoxiconazole] results in increased expression of XRCC1 mRNA CTD PMID:29038839 NCBI chr 1:81,412,635...81,441,680
Ensembl chr 1:81,413,353...81,441,678
JBrowse link
G Xrcc5 X-ray repair cross complementing 5 multiple interactions EXP [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA CTD PMID:29038839 NCBI chr 9:79,659,275...79,748,050
Ensembl chr 9:79,659,251...79,748,078
JBrowse link
G Yipf5 Yip1 domain family, member 5 increases expression ISO epoxiconazole results in increased expression of YIPF5 mRNA CTD PMID:22334560 NCBI chr18:33,401,103...33,436,885
Ensembl chr18:33,401,106...33,434,775
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19841
    chemical entity 19841
      molecular entity 19839
        main group molecular entity 19732
          gas molecular entity 17612
            oxirane 5776
              epoxide 5774
                1-\{[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl\}-1H-1,2,4-triazole 420
                  (2R,3S)-epoxiconazole + 420
                  (2S,3R)-epoxiconazole + 420
Path 2
Term Annotations click to browse term
  CHEBI ontology 19841
    subatomic particle 19839
      composite particle 19839
        hadron 19839
          baryon 19839
            nucleon 19839
              atomic nucleus 19839
                atom 19839
                  main group element atom 19732
                    p-block element atom 19732
                      carbon group element atom 19636
                        carbon atom 19625
                          organic molecular entity 19625
                            organic molecule 19556
                              organic cyclic compound 19365
                                organic heterocyclic compound 18486
                                  organic heteromonocyclic compound 16595
                                    saturated organic heteromonocyclic parent 5808
                                      oxirane 5776
                                        epoxide 5774
                                          1-\{[3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl\}-1H-1,2,4-triazole 420
                                            (2R,3S)-epoxiconazole + 420
                                            (2S,3R)-epoxiconazole + 420
paths to the root